Stay updated with breaking news from Full Maglev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The MOMENTUM 3 study showcases the significant survival benefits of Abbott's heart pump technology, particularly in a patient population with limited therapy options
New data from the MOMENTUM 3 study showed for the first time that a heart pump can extend survival to five years and beyond for advanced heart fai...
New data from the MOMENTUM 3 study showed for the first time that a heart pump can extend survival to five years and beyond for advanced heart failure patientsPrior data1 have shown survival
Abbott became the dominant provider of left ventricular assist devices (LVADs) after Medtronic's decision last year to leave the market.